Sign inJoin waitlistJoin the waitlist

Peter LeWitt

Director of Movement Disorder Fellowship Program WSU · Wayne State University School of Medicine

Credentials: · · ·

History

Wayne State University School of Medicine
Present
Wayne State University School of Medicine
Present

Rheumatology
1980–1982
Resident in Neurology Stanford University Medical Center
1977–1980
Philadelphia General Hospital
1975–1976
Alpert Medical School
1971–1975

Research

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results
Movement Disorders · 2008 · 5,677 citations
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan
Movement Disorders · 2007 · 1,064 citations
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
The Lancet Neurology · 2011 · First of 21 authors · 463 citations

Robert Hauser
17 papers
Rajesh Pahwa
16 papers
RN
Richard Newman
15 papers · 9 as a fellow
Christos Sidiropoulos
11 papers · 2 as a fellow
Nunzio Pomara
10 papers
Alberto Espay
9 papers
AD
Andrew Demaggio
9 papers · 3 as a resident
CO
C. Olanow
9 papers
Cheryl Waters
9 papers
Karl Kieburtz
9 papers
SF
Stanley Fahn
9 papers
Stuart Isaacson
9 papers

Grants

Southeastern Michigan Parkinson's Disease Program
National Institute of Neurological Disorders and Stroke · U10
Contact PI · $162K · William Beaumont Hospital Research Inst
2002–2007
Nocardia: A Novel Environmental Agent For Parkinsonism?
National Institute of Environmental Health Sciences · R01
Contact PI · $1M · William Beaumont Hospital Research Inst
2001–2005
Parkinson Disease Pathophysiology--Csf Markers
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $472.4K · Sinai Hospital of Detroit
1990–1992

Clinical trials

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Principal investigator · Unknown · Phase 3
Intec Pharma Ltd.
2016–2019
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
Principal investigator · Unknown · Phase 3
Intec Pharma Ltd.
2016–2019
Acamprosate and Methazolamide for Essential Tremor
Principal investigator · Withdrawn · Phase 2
Henry Ford Health System
2016–2017
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
Principal investigator · Unknown · Phase 2
Henry Ford Health System
2015–2017